… Of those, we selected the records of patients with anterior scleritis treated for 3 or more
months with systemic therapeutic agents, such as NSAIDs, SAIDs, IMT, and BRMs, and for whom …

… Scleritis is a heterogeneous group of diseases characterized … scleritis and associated diseases
have indicated that scleritis … -TNF and anti-B cell therapy. The widespread use of imaging …

… with NSAIDs, aggressive systemic therapy is often required to … New therapies presently
under investigation for scleritis … Oral corticosteroids are widely used in the therapy of scleritis …

… In patients with nodular scleritis, therapeutic failure for initial regimens occurred in 9% of …
line therapies helped control the scleritis. In patients with necrotizing scleritis, therapeutic failure …

… Oral corticosteroid therapy has been a mainstay of scleritis therapy, but recent data … patients
with local, noninfectious, and non-necrotizing scleritis. In one study of 68 eyes receiving up …

… of mild–moderate anterior scleritis, but caution that such therapies were often inadequate
to … non-infectious, non-necrotizing anterior scleritis using an oral NSAID as first-line therapy. …

… series of patients with posterior scleritis who responded to oral indomethacin therapy.
However, our patients with posterior scleritis did well on systemic corticosteroid therapy, with most …

… to scleritis associated with a severe course and refractory to immunosuppressive therapy.
None … In diffuse anterior scleritis or nodular scleritis, treatment with biologicals was started only …

… opportunities arise for randomized controlled therapeutic clinical trials. We report the outcome
of 11 cases of relapsing polychondritis with scleritis managed with prednisone, dapsone, …

… Biologic agents are increasingly used in the management of scleritis, not responding to
the conventional therapies. This review provides an overview of the various subtypes of …